Document Detail

Two-stage plans for the testing of binomial parameters.
MedLine Citation:
PMID:  6641235     Owner:  NLM     Status:  MEDLINE    
Two-stage plans, a middle course between fixed-sample-size plans and sequential plans, are a worthwhile tool. Attention is given to the testing of binomial parameters in two-stage plans. Tables are given for testing pi = 0.5 in one population, the sign-test situation. An example demonstrates how these tables can be used for testing the equality of the binomial parameters in two populations as well. Results of the two-stage plans are compared with fixed-sample-size plans, sequential plans, and other published results.
C De With
Related Documents :
8731005 - The appropriateness of the wilcoxon test in ordinal data.
18397525 - The statistical analysis of a clinical trial when a protocol amendment changed the incl...
17418375 - Vertical variations of particle number concentration and size distribution in a street ...
17938775 - Pseudo-precision in gene expression values can reduce efficiency.
474525 - Quantitation of rheumatoid factor activity by nephelometry.
13631195 - Photo-reactions in phycomyces; growth and tropic responses to the stimulation of narrow...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Controlled clinical trials     Volume:  4     ISSN:  0197-2456     ISO Abbreviation:  Control Clin Trials     Publication Date:  1983 Sep 
Date Detail:
Created Date:  1984-01-27     Completed Date:  1984-01-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006242     Medline TA:  Control Clin Trials     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  215-26     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Trials as Topic / methods*
Research Design*
Statistics as Topic*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Interaction between prognostic factors and treatment.
Next Document:  Overall prognosis as the primary criterion of outcome in a clinical trial.